LAUSR

Race, Rituximab, and Relapse in TTP.

Sign Up to like & get
recommendations!
1 Published in 2022 at "Blood"

DOI: 10.1182/blood.2022016640

Abstract: Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is characterized by recurring episodes of thrombotic microangiopathy causing ischemic organ impairment. Blacks are overrepresented in iTTP cohorts in the United States but racial disparities in iTTP outcomes and response… read more here.

Keywords: black patients; race rituximab; ittp; race ... See more keywords